Eterna Therapeutics
ERNA
#10589
Rank
โ‚น0.42 B
Marketcap
โ‚น14.47
Share price
3.32%
Change (1 day)
-94.29%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): -โ‚น6,436

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is -โ‚น7,278. In 2022 the company made an earnings per share (EPS) of -โ‚น11,941 an increase over its 2021 EPS that were of -โ‚น78,888.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น6,436
2022-โ‚น11,941-84.86%
2021-โ‚น78,888

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
โ‚น195.94-102.69%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
-โ‚น175.53-97.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
-โ‚น191.66-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.33-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
โ‚น117.65-101.62%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
โ‚น49.34-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA